Work

Mutation burden as a biomarker of response to immune checkpoint therapy in nine solid cancers.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.7_suppl.35

Authors: Shridar Ganesan, Gyan Bhanot, Janice M. Mehnert, Ann W. Silk, Jeffrey S. Ross, Dean Pavlick, Siraj Mahamed Ali, Paul Markowski, Howard L. Kaufman, Ryan J. Sullivan, Christine Marie Lovly, Jeffrey Alan Sosman, Douglas Buckner Johnson, Anil Betigeri, Kalyanasundaram Subramanian, Anshuman Panda

Institutions: Rutgers Cancer Institute, Rutgers, The State University of New Jersey, Albany Medical College, Foundation Medicine (United States), Massachusetts General Hospital, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Strand Life Sciences (India)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2796856840

Cites:

Cited by: 1

Related to: 10